Dose adjustment guidelines for medications in patients with renal impairment: How consistent are drug information sources?

Internal Medicine Journal

Volumn 44, Issue 1, 2014, Pages 77-85

  Khanal, A ^a   Castelino, R L ^a   Peterson, G M ^a   Jose, M D ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Dosage adjustment; Drug prescribing; Guideline; Kidney disease; Renal impairment

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; BACLOFEN; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CODEINE; COLCHICINE; DIGOXIN; DULOXETINE; ENOXAPARIN; ETIRACETAM; GLIBENCLAMIDE; GLIMEPIRIDE; HYDROMORPHONE; LITHIUM; METFORMIN; METHOTREXATE; METOCLOPRAMIDE; MORPHINE; OXYCODONE; PARATHYROID HORMONE[1-34]; SITAGLIPTIN; SPIRONOLACTONE; STRONTIUM RANELATE; TOPIRAMATE; TRAMADOL; UNINDEXED DRUG; VARDENAFIL; VENLAFAXINE;

ARTICLE; CHRONIC KIDNEY DISEASE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG INFORMATION; EVIDENCE BASED PRACTICE; HOSPITAL PATIENT; HUMAN; KIDNEY DISEASE; LOADING DRUG DOSE; PRESCRIPTION; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

DOSAGE ADJUSTMENT; DRUG PRESCRIBING; GUIDELINE; KIDNEY DISEASE; RENAL IMPAIRMENT;

DRUG DOSAGE CALCULATIONS; DRUG INFORMATION SERVICES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS;

EID: 84892876886     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12291     Document Type: Article

References (44)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
2. Bowling CB, O'Hare AM. Managing older adults with CKD: individualized versus disease-based approaches. Am J Kidney Dis 2012; 59: 293-302.
3. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285.
4. Olyaei AJ, Steffl JL. A quantitative approach to drug dosing in chronic kidney disease. Blood Purif 2011; 31: 138-145.
5. Fink JC, Brown J, Hsu VD, Seliger SL, Walker L, Zhan M. CKD as an underrecognized threat to patient safety. Am J Kidney Dis 2009; 53: 681-688.
6. Fink JC, Chertow GM. Medication errors in chronic kidney disease: one piece in the patient safety puzzle. Kidney Int 2009; 76: 1123-1125.
7. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989; 321: 303-309.
8. Cantu TG, Ellerbeck EF, Yun SW, Castine SD, Kornhauser DM. Drug prescribing for patients with changing renal function. Am J Hosp Pharm 1992; 49: 2944-2948.
9. Aronoff G, Brater DC, Schrier R, Bennett WM. Use of drugs in patients with renal insufficiency. Workshop report. Blood Purif 1994; 12: 14-19.
10. Markota NP, Markota I, Tomic M, Zelenika A. Inappropriate drug dosage adjustments in patients with renal impairment. J Nephrol 2009; 22: 497-501.
11. Wong NA, Jones HW. An analysis of discharge drug prescribing amongst elderly patients with renal impairment. Postgrad Med J 1998; 74: 420-422.
12. Papaioannou A, Clarke JA, Campbell G, Bedard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000; 48: 1470-1473.
13. Akbari A, Swedko PJ, Clark HD, Hogg W, Lemelin J, Magner P etal. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med 2004; 164: 1788-1792.
14. Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qin J etal. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 2005; 16: 2439-2448.
15. Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V etal. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 2003; 15: 331-335.
16. van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother 2006; 40: 1254-1260.
17. Sweileh WM, Janem SA, Sawalha AF, Abu-Taha AS, Zyoud SH, Sabri IA etal. Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine. Pharmacoepidemiol Drug Saf 2007; 16: 908-912.
18. Vidal L, Shavit M, Fraser A, Paul M, Leibovici L. Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 2005; 331: 263-266.
19. Rossi S. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2012.
20. Joint Formulary Committee. British National Formulary (Online). London: BMJ group and Pharmaceutical press; 2012 [cited 2012 Jun 20]. Available from URL: http://www.medicinescomplete.com
21. McEvoy GK, Miller J, Snow EK, Welsh OH, Litvak K. AHFS: Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2012.
22. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003; 33: 10-13.
23. MIMS Australia. Emims. version 5.01.0111. Sydney: CMP Medica Australia; 2006.
24. Arnoff GR, Berns JS, Brier ME. Drug Prescribing in Renal Failure, 5 edn. Philadelphia, PA: American College of Physicians; 2007.
25. Veterans' MATES. Veterans' Medicines Advice and Therapeutics Education Services. Therapeutic brief 30 - know your patient's renal function - an important prescribing consideration. Department of Veterans Affairs. 2012 [cited 2012 Sep 13]. Available from URL: https://www.veteransmates.net.au/VeteransMATES/documents/module_materials/M30_TherBrief.pdf
26. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
27. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educational and psychological measurement. Educ Psychol Meas 1973; 33: 613-619.
28. Allan PJ, Lee AJ, Mark CB, Deborah SM. Apples and oranges: an empirical comparison of commonly used indices of interrater agreement. Acad Manage J 1983; 26: 507-519.
29. Hartmann DP. Considerations in the choice of interobserver reliability estimates. J Appl Behav Anal 1977; 10: 103-116.
30. Freelon DG. ReCal: intercoder reliability calculation as a web service. Int J Internet Sci 2010; 5: 20-33.
31. Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA etal. Glomerular filtration rate measurements in clinical trials. Modification of diet in renal disease study group and the diabetes control and complications trial research group. J Am Soc Nephrol 1993; 4: 1159-1171.
32. Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners. Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral. London: Royal College of Physicians; 2006.
33. Johnson D. The CARI Guidelines - Caring for Australasians with Renal Impairment. Diagnosis, classification and staging of chronic kidney disease. 2012 [cited 2013 Jan 16]. Available from URL: http://www.cari.org.au/CKD_early_CKD/Diag_Classification_Staging_ECKD.pdf
34. Hanlon JT, Aspinall SL, Semla TP, Weisbord SD, Fried LF, Good CB etal. Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc 2009; 57: 335-340.
35. McEvoy GK. Letter to editor: response from AHFS Drug Information. BMJ 2012; 331: 293.
36. Decloedt E, Leisegang R, Blockman M, Cohen K. Dosage adjustment in medical patients with renal impairment at Groote Schuur Hospital. S Afr Med J 2010; 100: 304-306.
37. Neetu S, Sandeep B, Anita G. An analysis and comparison of commonly available prescribing information resources in north indian set up. J App Pharm Sci 2012; 2: 193-196.
38. Jones GR, Mathew T, Johnson D, Peake M. Implementation of the routine reporting of eGFR in Australia and New Zealand. Scand J Clin Lab Invest Suppl 2008; 241: 23-29.
39. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005; 183: 138-141.
40. Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Doogue MP, Jose MD etal. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust 2012; 197: 224-225.
41. Rational Assessment of Drugs and Research (RADAR). Automatic eGFR reporting - its role in screening for kidney disease and drug-dosing decisions 2008 [cited 2012 Sep 10]. Available from URL: http://www.nps.org.au/publications/health-professional/nps-radar/2008/august-2008/egfr
42. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010; 5: 1003-1009.
43. Arnoff GR. Letter to editor: response from Drug Prescribing in Renal Failure. BMJ 2012; 331: 293-294.
44. Dinesh KM. Letter to editor: response from the British National Formulary. BMJ 2005; 331: 292.